Company

PNP Therapeutics, Inc.

PNP Therapeutics develops Gedeptin, a cancer treatment technology targeting tumor cells.

About

Founded in Birmingham, Alabama, in 2000, PNP Therapeutics develops Gedeptin, a cancer treatment technology intended to target tumor cells. The company has licensed the technology to GeoVax, Inc. In May 2012, it raised USD 0.67 mn in Series B funding from Greer Capital.

3Funding rounds

1Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in